Zometa Facts:

Recently, studies have shown that there may be a link between the use of bisphosphonates, including Zometa, and osteonecrosis of the jaw, also known as "jaw death." The condition is often associated with the interference of the blood supply to the bone. The condition of jaw death may be triggered in the jaw by oral surgery or having teeth pulled. Osteonecrosis of the jaw can be extremely painful and may lead to additional complications, such as infection, breakdown of the jawbone, and ulcerations in the lining of the mouth.

Usage:

Zometa is a common intravenous bisposphonate similar to Actonel, Aredia, Boniva, and Fosamax. It is prescribed to prevent bone loss, but has very serious side effects including the development of a condition known as Osteonecrosis of the Jaw (ONJ). ONJ causes the jaw bone to degenerate, resulting in serious and irreparable side effects including bone loss, pain, numbness, and exposed bone. Other side effects of Zometa include difficulty breathing, kidney problems and low levels of calcium..

Litigation:

On April 10, 2006, a class action lawsuit was filed against Merck reagarding a similar drug, charging that Fosamax causes osteonecrosis of the jaw. It also claims that Merck knew about this risk and hid it from the public. It is estimated that there are currently 10 million Fosamax users. If you suffer from dead jaw, Osteonecrosis or bone death as a result of taking Zometa you may be eligible for compensation. Please fill out the form to the right and your submission will be forwarded to an experienced DrugSettlement.com attorney or representative who will contact you for a free and confidential evaluation.